Blogs

RLS AND SOFIE ENTER STRATEGIC PARTNERSHIP FOR DISTRIBUTION OF NUCLEAR MEDICINE DOSES FOR PATIENTS

SOFIE to Manufacture Batches, RLS to Compound and Distribute to SOFIE Customers, Improving Continuum of Care for Patients

Read More

RLS APPOINTS GLENN SULLIVAN AS DIRECTOR OF REGULATORY AFFAIRS

New Appointment Marks Latest in RLS’s Commitment to Best-in-Class Regulation as Radiopharmacy Network Continues to Scale for Long-Term Growth

Read More

SpectronRx and RLS Team Up to Give the Radiopharmaceutical Pipeline and Supply Chain a Much-Needed Boost

Marks Latest Step in RLS Expansion into Oncology & Work to Create an Unbroken Chain of Patient Care from Clinical Trial to Commercial Supply

Read More

RLS Awarded Radiopharmaceutical Products (Distributor) Agreement with Premier, Inc.

LAKE ZURICH, IL., June 5, 2023 /PRNewswire/ — RLS (USA), Inc. (Radioisotope Life Sciences), the third-largest nuclear medicine pharmacy network in the US, has been awarded a national group purchasing agreement for the distribution of Radiopharmaceutical Products with Premier, Inc, a leading healthcare improvement company headquartered in Charlotte, North Carolina. […]

Read More

RLS & Evergreen Partnership for Drug Candidate OCTEVY™

Expands RLS Capabilities and Offerings across the US, Begins to Establish Commercial Footprint for Evergreen

Read More

QSAM Biosciences and RLS Announce Clinical and Commercial Supply Agreement for Promising Clinical-Stage Metastatic and Primary Bone Cancer Treatment, CycloSam

Partnership is Latest in Series of RLS Efforts to Expand Industry-Leading CDMO Business and Clinical Trial Capability with Radiopharmaceutical Partners Across U.S.

Read More

Rls Names Radiopharmacy and Healthcare Leader Trey Bankson as New Chief Operating Officer

Bankson’s Appointment Marks the Latest in Recent Slate of Executive Hires to Position RLS for Long-Term, Sustainable Growth and Success.

Read More